Healthcare provider profile · identity verified

Raquel M Montero

Nurse Practitioner · YUBA CITY, CA · NPI 1508330630

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	362	120
Amlodipine Besylate	Amlodipine Besylate	305	103
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	302	102
Gabapentin	Gabapentin	266	63
Losartan Potassium	Losartan Potassium	226	65
Levothyroxine Sodium	Levothyroxine Sodium	183	57
Metoprolol Succinate	Metoprolol Succinate	169	48
Lisinopril	Lisinopril	158	52
Metformin Hcl	Metformin Hcl	157	48
Omeprazole	Omeprazole	141	43
Pantoprazole Sodium	Pantoprazole Sodium	128	35
Furosemide	Furosemide	122	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	121	28
Escitalopram Oxalate	Escitalopram Oxalate	121	35
Trazodone Hcl	Trazodone Hcl	120	34
Montelukast Sodium	Montelukast Sodium	117	32
Zolpidem Tartrate	Zolpidem Tartrate	115	30
Potassium Chloride	Potassium Chloride	114	33
Tramadol Hcl	Tramadol Hcl	104	30
Alprazolam	Alprazolam	99	27
Meloxicam	Meloxicam	91	23
Temazepam	Temazepam	79	suppressed
Prednisone	Prednisone	78	63
Hydrochlorothiazide	Hydrochlorothiazide	77	23
Allopurinol	Allopurinol	71	22
Simvastatin	Simvastatin	69	24
Pregabalin	Pregabalin	68	13
Lorazepam	Lorazepam	66	18
Sertraline Hcl	Sertraline Hcl	66	14
Naproxen	Naproxen	65	15
Ozempic	Semaglutide	65	14
Albuterol Sulfate Hfa	Albuterol Sulfate	64	31
Quetiapine Fumarate	Quetiapine Fumarate	63	14
Pioglitazone Hcl	Pioglitazone Hcl	62	20
Januvia	Sitagliptin Phosphate	59	15
Raloxifene Hcl	Raloxifene Hcl	57	16
Ondansetron Odt	Ondansetron	56	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	19
Alendronate Sodium	Alendronate Sodium	52	12
Fluoxetine Hcl	Fluoxetine Hcl	52	11
Tamsulosin Hcl	Tamsulosin Hcl	52	21
Azithromycin	Azithromycin	51	41
Metoprolol Tartrate	Metoprolol Tartrate	51	15
Famotidine	Famotidine	50	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	17
Clonazepam	Clonazepam	48	suppressed
Ibuprofen	Ibuprofen	48	23
Baclofen	Baclofen	47	17
Ezetimibe	Ezetimibe	47	20
Duloxetine Hcl	Duloxetine Hcl	46	15
Fluticasone Propionate	Fluticasone Propionate	46	16
Rosuvastatin Calcium	Rosuvastatin Calcium	46	15
Jardiance	Empagliflozin	44	15
Mirtazapine	Mirtazapine	44	12
Glipizide Er	Glipizide	43	12
Buspirone Hcl	Buspirone Hcl	41	14
Carvedilol	Carvedilol	41	13
Morphine Sulfate Er	Morphine Sulfate	41	13
Ventolin Hfa	Albuterol Sulfate	41	12
Triamcinolone Acetonide	Triamcinolone Acetonide	40	26
Eliquis	Apixaban	37	13
Ibandronate Sodium	Ibandronate Sodium	36	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	11
Donepezil Hcl	Donepezil Hcl	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	16
Nystatin	Nystatin	35	16
Propranolol Hcl	Propranolol Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Lactulose	Lactulose	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	18
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Topiramate	Topiramate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Bumetanide	Bumetanide	22	11
Cromolyn Sodium	Cromolyn Sodium	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	20
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Estradiol	Estradiol	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Glipizide	Glipizide	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Dexamethasone	Dexamethasone	14	11
Finasteride	Finasteride	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Diazepam	Diazepam	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error